Advanced search
Publication Cover
Biotechnology & Biotechnological Equipment Volume 31, 2017 - Issue 1
Submit an article Journal homepage
825
Views
1
CrossRef citations to date
0
Altmetric
Article; Medical Biotechnology

Impact of KCNQ2 mutations in Bulgarian patients with electroclinical syndromes with onset in the first year of life

Valentina PeychevaDepartment of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University of Sofia, Sofia, BulgariaCorrespondence[email protected]
View further author information
,
Neviana IvanovaDepartment of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University of Sofia, Sofia, BulgariaView further author information
,
Kunka KamenarovaDepartment of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University of Sofia, Sofia, BulgariaView further author information
,
Irina TsekovaDepartment of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University of Sofia, Sofia, BulgariaView further author information
,
Iliyana AleksandrovaDepartment of Neurology, Clinic of Child Neurology, University Hospital of Neurology and Psychiatry “St' Naum”, Medical University of Sofia, Sofia, BulgariaView further author information
,
Veneta BozhinovaDepartment of Neurology, Clinic of Child Neurology, University Hospital of Neurology and Psychiatry “St' Naum”, Medical University of Sofia, Sofia, BulgariaView further author information
,
Maria BozhidarovaDepartment of Pediatric Neurology, University Pediatrics Hospital, Medical University of Sofia, Sofia, BulgariaView further author information
,
Ivan LitvinenkoDepartment of Pediatric Neurology, University Pediatrics Hospital, Medical University of Sofia, Sofia, BulgariaView further author information
,
Dimitrina HristovaChildren Neurology Unit, Pediatrics Clinic, Tokuda Hospital, Sofia, BulgariaView further author information
,
Vanyo MitevDepartment of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University of Sofia, Sofia, BulgariaView further author information
,
Radka KanevaDepartment of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University of Sofia, Sofia, BulgariaView further author information
&
Albena JordanovaDepartment of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University of Sofia, Sofia, Bulgaria;VIB Department of Molecular Genetics, Molecular Neurogenomics Group, University of Antwerp, Antwerp, BelgiumView further author information
 show all
Pages 138-142 | Received 18 Aug 2016, Accepted 07 Nov 2016, Published online: 30 Nov 2016

References

  • Deprez L, Jansen A, De Jonghe P. Genetics of epilepsy syndromes starting in the first year of life. Neurology. 2009;72(3):273–281.
  • Loiseau P, Duché B, Cordova S, et al. Prognosis of benign childhood epilepsy with centrotemporal spikes: a follow-up study of 168 patients. Epilepsia. 1988;29(3):229–235.
  • Maihara T, Tsuji M, Higuchi Y, et al. Benign familial neonatal convulsions followed by benign epilepsy with centrotemporal spikes in two siblings. Epilepsia. 1999;40(1):110–113.
  • Coppola G, Castaldo P, Miraglia Del Giudice E, et al. A novel KCNQ2 K+channel mutation in benign neonatal convulsions and centrotemporal spikes. Neurology. 2003;61(1):131–134.
  • Ishii A, Miyajima T, Kurahashi H, et al. KCNQ2 abnormality in BECTS: benign childhood epilepsy with centrotemporal spikes following benign neonatal seizures resulting from a mutation of KCNQ2. Epilepsy Res. 2012;102(1–2):122–125.
  • Zara F, Specchio N, Striano P, et al. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance. Epilepsia. 2013;54(3):425–436.
  • Wen H, Levitan B. Calmodulin is an auxiliary subunit of KCNQ2/3 potassium channels. J Neurosci. 2002;22(18):7991–8001.
  • Yus-Nájera E, Santana-Castro I, Villarroel A. The identification and characterization of a noncontinuous calmodulin-binding site in noninactivating voltage-dependent KCNQ potassium channels. J Biol Chem. 2002;277(32):28545–28553.
  • Steinlein O, Conrad C, Weidner B. Benign familial neonatal convulsions: always benign? Epilepsy Res. 2007;73(3):245–249.
  • Singh NA, Westenskow P, Charlier C, et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain. 2003;126(12):2726–2737.
  • Kurahashi H, Wang J, Ishii A, et al. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures. Neurology. 2009;73(15):1214–1217.
  • Okumura A, Ishii A, Shimojima K, et al. Phenotypes of children with 20q13.3 microdeletion affecting KCNQ2 and CHRNA4. Epileptic Disord. 2015;17(2):165–171.
  • Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 1999;398(6730):805–810.
  • Béri-Deixheimer M, Gregoire M, Toutain A, et al. Genotype–phenotype correlations to aid in the prognosis of individuals with uncommon 20q13.33 subtelomere deletions: a collaborative study on behalf of the ‘association des Cytogénéticiens de langue Française’. Eur J Hum Genet. 2007;15(4):446–452.
  • Pascual F, Wierenga K, Ng Y. Contiguous deletion of KCNQ2 and CHRNA4 may cause a different disorder from benign familial neonatal seizures. Epilepsy Behav Case Rep. 2013;1:35–38.
  • Allen NM, Mannion M, Conroy J, et al. The variable phenotypes of KCNQ-related epilepsy. Epilepsia. 2014;55(9):e99–e105.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.